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Abstract
Receptor signaling is mediated by direct protein interaction with various types of cytoskeletal, adapter, effector, and additional receptormolecules.
In brain tissue and in cultured neurons, activation of dopamine D2 receptors (D2Rs) has been found to impact cellular calcium signaling. Using a
yeast two-hybrid approach, we have uncovered a direct physical interaction between the D2R and the transient receptor potential channel (TRPC)
subtypes 1, 4 and 5. The TRPC/D2R interaction was further validated by GST-pulldown assays and coimmunoprecipitation from mammalian brain.
Ultrastructural analysis of TRPC1 and D2R expression indicates colocalization of the two proteins within the cell body and dendrites of cortical
neurons. In cultured cells, expression of D2Rs was found to increase expression of TRPC1 at the cell surface by 50%. These findings shed new light
on the constituents of the D2R signalplex, and support the involvement of D2Rs in cellular calcium signaling pathways via a novel link to TRPC
channels.
© 2008 Elsevier B.V. All rights reserved.Keywords: Dopamine receptor; Transient receptor potential; TRPC1; G-protein coupled receptor; Interacting proteins; Calcium signaling1. Introduction
Dopamine is a catecholamine neurotransmitter that regula-
tes important cognitive and behavioral functions in the mam-
malian brain including locomotion, memory, attention, and
reward [1–3]. Dopamine exerts its effects through the activa-
tion of dopamine receptors (DRs) and their subsequent coupling
to downstream effector molecules [4]. Alterations in dopami-
nergic neurotransmission have been implicated in a variety of
neurological and neuropsychiatric conditions including schi-
zophrenia [5–7], with the majority of antipsychotic drugs act-
ing as antagonists at D2R sites in the brain [8,9]. It has recently
been suggested that dysregulation of dopaminergic signaling,
a feature of disorders such as schizophrenia, may stem from⁎ Corresponding author. Tel.: +1 717 531 4545; fax: +1 717 531 5013.
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doi:10.1016/j.bbamem.2008.01.011alterations in expression or function of proteins that interact
with and regulate DR-mediated signaling [10,11].
The DR family, consisting of the D1-like and D2-like re-
ceptors, has been shown to associate with diverse intracellular
signaling pathways in neurons. D2Rs are primary regulators of
the inhibitory Gi/o pathways but can also activate calcium-
associated signaling pathways, including the canonical Gq/PLC
pathway, and can mediate the mobilization of intracellular
calcium stores and activation of calcium-dependent phosphatases
[12–14]. A number of proteins have now been identified that
interact with DRs (dopamine receptor interacting proteins;
DRIPs) and regulate the life cycle and signaling properties of
individual DR subtypes (reviewed in [15,16]). For example,
interaction of D2Rs with calcium binding proteins such as NCS-1
[17] and CAPS [18] plays an important role in D2R desensitiza-
tion and dopamine secretion, respectively.
In the present study, we used the second intracellular loop of
the D2R (D2IC2) as bait in a yeast two-hybrid screen and
identified TRPC1 (transient receptor potential channel 1) as a
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(TRPC1–7) have been identified based on sequence similari-
ties to Drosophila TRP (reviewed in [19]), and have been
shown to function in a variety of physiological processes
including Ca2+ and Na+ entry, receptor/phospholipase C (PLC)
signaling, lipid raft integrity, cell volume regulation, and cell
proliferation (reviewed in [20]). Homomeric TRPC1 has been
reported to function as either a store-operated, receptor-
operated, or DAG-activated ion channel [19,21]. It has been
suggested that TRPC1 may also represent a non-functional ion
channel subunit [22]. Our data indicate that TRPC1 interacts
with the D2R in native brain tissue, and that this interaction
enhances the delivery of TRPC1 to the cell surface. Ultra-
structural analysis of native TRPC1 and D2R proteins using
electron microscopy shows that these proteins colocalize in
postsynaptic compartments of cortical neurons in the pri-
mate cortex. These findings reveal a novel link between D2Rs
and TRPC channels in neurons, and suggest a role for TRPC
channels in neuropsychiatric disease.
2. Experimental methods
2.1. DNA constructs and yeast two-hybrid assays
All constructs were generated by subcloning PCR amplification or restriction
enzyme fragments into appropriate expression vectors, and each construct was
verified by automated DNA sequencing. For the yeast two-hybrid screen, the
second intracellular loop of the human D2R (D2IC2, amino acids 131–151) was
subcloned into the yeast GAL4 DNA-binding domain vector pAS2-1 (BD
Biosciences Clonetech) and used as bait to screen a human fetal brain cDNA
library expressed in the GAL4 activation domain vector pACT2 (BDBiosciences
Clonetech). Bait and prey constructs were simultaneously cotransformed into the
yeast strain MaV103, and 1×106 independent clones were screened by selective
growth on Leu-/Trp-/His-/Ade- plates as described previously [18]. Protein
interactionwas assayed for byβ-galactosidase activity via the nitrocellulose filter
lift method [23].
Sites within human DRs and TRPCs that contribute to the TRPC/DR
interaction were mapped using a directed two-hybrid approach. The IC2 domain
of the D2R (in pAS2-1) was assayed for interaction against truncation fragments
of TRPC1, TRPC4, or TRPC5 (in pACT2). TRPC cDNAs were generously
provided by Drs. Michael Schaefer (University of Berlin), Craig Montell (Johns
Hopkins University), and David Beech (University of Leeds). Bait and prey
plasmids were sequentially transformed into the yeast strain MaV103 and
interactions were assayed as described above.
2.2. GST-pulldown and coimmunoprecipitation
Glutathione S-transferase (GST)–D2IC2 fusion protein (GST–D2IC2) and
GST–D2LIC3 fusion protein (residues 211–373) were constructed in the
bacterial expression vector pGEX-4T-1 (Amersham Pharmacia), while carboxyl-
terminal truncations of TRPC1 (residues 638–759), TRPC4 (residues 621–893),
and TRPC5 (residues 619–973) were constructed in the pET30C vector (Amer-
sham Pharmacia) to generate S-tagged protein fragments. All fusion proteins
were induced in E. coli strain BL-21 (DE3). GST–D2IC2 and GST–D2LIC3
fusion proteins were purified using glutathione–sepharose (Amersham) accord-
ing to the manufacturer's instructions. GST-pulldown assays were performed as
described previously [23]. Eluted proteins were separated by SDS-PAGE and
transferred to a polyvinylidene difluoride (PVDF) filter and probed with an anti-
S-protein polyclonal antibody conjugated to horseradish peroxidase (1:5000
dilution; Novagen). Immunoreactivity was detected by enhanced chemilumines-
cence with an ECL Plus kit (Amersham).
For coimmunoprecipitation experiments, striatal and cortical tissue were iso-
lated from 10-day-old Sprague–Dawley rats. Crude membranes were prepared
and membrane proteins solubilized as previously described [24]. Immunopreci-pitation of D2R complexes was performed using a goat polyclonal anti-D2R
antibody (Santa Cruz Biotechnology). Immunocomplexes were separated by SDS-
PAGE, transferred to a PVDF filter, and the filter sequentially probed with a
monoclonal anti-TRPC1 antibody (generous gift from Dr. Leonidas Tsiokas,
University of Oklahoma Health Sciences Center), a rabbit polyclonal anti-TRPC4
antibody (Chemicon), or a chicken polyclonal anti-NCS-1 antibody (Rockland
Immunochemicals, Gilbertsville, PA). Peroxidase-conjugated secondary antibo-
dies were from Jackson ImmunoResearch (West Grove, PA). Immunoreactivity
was detected using an ECL Plus kit. The specificity of themonoclonal anti-TRPC1
antibody has been previously demonstrated [25]. In Western blot analysis of
HEK293 cell membrane fractions and rat brain lysates, two different commercially
available polyclonal anti-TRPC1 antibodies (Alomone; Sigma) identified a pro-
tein migrating with the same molecular mass as the protein detected with the
monoclonal anti-TRPC1 antibody. Using this approach, the polyclonal anti-
TRPC4 antibody (Chemicon) detected a protein at the predicted molecular weight
of TRPC4,whereas the polyclonal anti-TRPC5 antibody (Chemicon) cross-reacted
with an unknown protein of a smaller molecular mass than that predicted for
TRPC5 [26].
2.3. Immunoelectron microscopy
Two adult rhesus monkeys (Macaca mulatta) were perfused, and brain tissue
was prepared as described previously [27]. Affinity-purified polyclonal rabbit
antibodies directed against human D2R (amino acids 284–311) and human
TRPC1 (amino acids 557–571) were purchased fromChemicon (Temecula, CA).
Sections of the dorsolateral prefrontal cortex (Walker's area 46) were processed
for electron microscopy as previously described [28].
For single gold-based immunocytochemistry, sections were incubated in either
anti-D2R (diluted 1:500) or anti-TRPC1 (diluted 1:200) antibodies, and trans-
ferred to nanogold-anti-rabbit Fab′ (Nanoprobes, Yaphank, NY) or biotinylated
anti-rabbit F(ab′)2 (Jackson ImmunoResearch) and nanogold-anti-biotin Fab
(Nanoprobes), as previously described [27,28]. Nanogoldwas enhancedwith silver
autometallographic developer (HQ Silver; Nanoprobes).
For dual gold-based immunocytochemistry, sections were incubated in anti-
D2R (1:300 dilution) antibody, followed by nanogold-anti-rabbit Fab′ and gold
enhancement (GoldEnhance; Nanoprobes). An excess of unconjugated goat anti-
rabbit Fab (1:10–50; Jackson ImmunoResearch) and mild glutaraldehyde
fixation was used to neutralize any remaining rabbit proteins. Sections were
incubated in anti-TRPC1 (1:100 dilution) antibody and a second series of nano-
gold conjugates, followed by gold autometallography to enhance the TRPC-1-
bound nanogold as previously described [29]. TRPC1 was labeled in the second
series using biotinylated anti-rabbit F(ab′)2 followed by unconjugated anti-rabbit
Fab and fixation. TRPC1 was visualized with peroxidase and diaminobenzidine
chromogen, while D2Rs were visualized with nanogold as detailed above for
single immunocytochemistry [28], and sampled for thin-sectioning and analysis
under a JEM 1010 (Jeol, Tokyo, Japan) transmission electron microscope
operated at 80 kV.
2.4. Cell culture and cell surface biotinylation assay
Human embryonic kidney (HEK) 293T cells were maintained in Dulbecco's
modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum.
HEK293 cells stably expressing FLAG-tagged D2L (long-splice isoform) dopamine
receptors (HEK293-D2L) or FLAG-tagged µ-opiod receptors (HEK293-MOR)were
provided by Dr. Mark von Zastrow (University of California San Francisco).
HEK293-D2L and HEK293-MOR cell lines were maintained in Dulbecco's modi-
fied Eagle's medium supplemented with 10% fetal bovine serum and 300 μg/ml
Geneticin (Invitrogen, Grand Island, NY).
Cell surface labeling assays were performed using a modification of the
cleavable biotin method described previously [49]. Briefly, cells were labeled
with 1 mg/ml sulfo-NHS-SS-biotin (Pierce, Rockford IL) for 30 min at 4 °C.
Cells were washed three times with ice cold phosphate buffered saline (PBS) to
remove unbound biotin, and crude membrane fractions prepared as described
previously [30]. Biotin-labeled TRPC1 proteins were immunoprecipitated using
polyclonal anti-TRPC1 antibodies (Alomone Labs). Complexes were washed
repeatedly with ice cold PBS, resolved by SDS-PAGE, and transferred to a PVDF
membrane. The biotinylated proteins were complexed with avidin-conjugated
horseradish peroxidase (Vectastain Elite ABC detection system; Vector
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kit. Immunoblots were quantitated using a laser densitometer (Molecular
Dynamics, Sunnyvale, CA) and analyzed using the Quantity One software
package (PDI, Inc., Huntington Station, NY).3. Results
3.1. Interaction between D2 dopamine receptors and TRPC
proteins
We carried out a yeast two-hybrid screen using the 22 amino
acid-long second intracellular domain of the D2R (D2IC2) as
bait to screen a human brain cDNA library. The D2IC2 domain
has previously been shown to interact with CAPS1 (calcium-
activated protein for secretion), a presynaptic calcium binding
protein that links D2Rs with components of the exocytic ma-
chinery [18]. In control experiments, neither the D2IC2 con-
struct nor any of the other bait constructs used in these studies
was found to autoactivate β-galactosidase expression (data not
shown). Using the D2IC2 construct as bait, a positive interact-
ing cDNA clone was identified (Fig. 1A) that contained an
~200 base pair cDNA insert. Analysis of the predicted amino
acid sequence revealed 100% identity with the carboxyl-
terminal 65 residues of TRPC1 (transient receptor potential
channel 1). The interaction between TRPC1 and the D2IC2
appeared to be specific, as the TRPC1 cDNA failed to interact
with the D2R IC3 domain, and the D2IC2 domain failed to
interact with protein 4.1N (Fig. 1A). Protein 4.1N has previously
been shown to interact with a region within the D2IC3 domain
[31]. TRPC1 is one of seven (TRPC1–TRPC7) mammalian
TRPC channels involved in agonist-stimulated Ca2+ influx (for
reviews see [20,32,33]) and store-operated Ca2+ release
(reviewed in [20]).
The TRPC1/D2R interaction was initially validated using
pulldown techniques. A lysate prepared from bacteria expres-
sing an S-tagged TRPC1 carboxyl-terminal cDNA fragment
(residues 638–759) was tested for the ability to associate withFig. 1. Interaction between the D2R and TRPC proteins. (A) Results from a yeast t
(1) but not with an unrelated bait (D2IC3L; 3) or protein 4.1N (4). Interaction betwe
D2R associates with TRPC1. D2IC2–GST fusion protein pulled down S-tagged T
detected when the lysate was absorbed onto beads alone (control lane) or beads con
TRPC5 proteins. The D2IC2 fusion protein pulled down S-tagged TRPC4 (residues 62
lysates. Only very faint immunoreactive bands were detected when lysates were absa GST fusion protein containing the D2IC2 domain (D2IC2–
GST). As shown in Fig. 1B, a Western blot containing lysate
from bacteria expressing the S-tagged TRPC1 construct pro-
duced an immunoreactive band of ~18 kDa when probed with
an anti-S-protein antibody (lane 1). This band corresponds to the
expected size of the C-terminal TRPC1 fragment encoded by
the cDNA construct. The same band was detected by pulldown
after the bacterial lysate was incubated with the D2IC2–GST
fusion protein (lane 4), but not when the lysate was absorbed
onto beads alone (lane 2) or beads containing GST (lane 3).
These results support the validity of the TRPC1/D2R interaction.
TRPC1 is most closely related in amino acid sequence to
TRPC4 and TRPC5 and can form functional heteromeric chan-
nels with either of these TRPC subtypes [19]. Based on these
considerations, we used the GST-pulldown assay to investi-
gate whether the D2R might also interact with TRPC4 and/or
TRPC5. As shown in Fig. 1C, Western blots containing lysates
prepared from bacteria expressing S-tagged TRPC4 (residues
621–893; top panel) or TRPC5 (residues 619–973; bottom
panel) C-terminal fragments were probed with anti-S-tag anti-
bodies. Immunoreactive bands of the expected sizes were vi-
sualized in the bacterial lysates (lane 1) and after pulldown with
the D2IC2–GST fusion protein (lane 2). No immunoreactive
bands were visible when the lysates were incubated either
with beads alone (data not shown) or with beads containing GST
(lane 3). These results suggest that the IC2 of the D2R interacts
directly with TRPC4 and TRPC5, as well as TRPC1.
3.2. Mapping protein interaction domains
Deletion mapping was performed to localize sites within
TRPC1 that contribute to D2R interaction. A series of trunca-
tion fragments of the C-terminal domain of TRPC1 (Clone 44,
amino acids 638–759) were tested for interaction with the
D2IC2 domain in a directed yeast two-hybrid screen. As shown
in Fig. 2B, TRPC truncation constructs A (residues 638–693)
and B (residues 638–726) failed to interact with D2IC2 in thewo-hybrid screen showing interaction between TRPC1 and the D2IC2 domain
en CAPS and the D2IC2 domain (2) was included as a positive control. (B) The
RPC1 (residues 638–759) from a bacterial lysate. Only very faint bands were
taining GST protein (GST lane). (C) The D2R also interacts with TRPC4 and
1–893; upper panel) and TRPC5 (residues 619–973; lower panel) from bacterial
orbed onto beads containing GST protein (GST lane).
Fig. 2. Localization of the D2R binding site on TRPC1, TRPC4 and TRPC5.
Schematic representation of constructs encoding truncations of TRPC1.
(A) Full-length TRPC1 protein. Shaded boxes depict ankyrin repeats (ANK),
shaded ovals represent transmembrane (TM) segments, and black box depicts
the pore loop domain (PL). Residues 694–759 encompass the C-terminal
fragment (Clone 44) identified in the original yeast two-hybrid screen.
(B) TRPC1 truncation fragments A–E were tested for interaction with the
D2IC2 domain in the two-hybrid assay. Interaction is indicated by the pre-
sence (+) or absence (−) of β-galactosidase activity. (C) Amino acid sequence
alignment of TRPC1, TRPC4, and TRPC5 in the C-terminal region found to
contain the D2IC2 binding site. Amino acids are numbered to the left and
right of each line. Identical amino acids are highlighted in black, and conserved
amino acids are highlighted in grey. (D) Representative β-galactosidase assays
comparing the interaction of D2IC2 with Clone 44 (residues 694–759 of
TRPC1; 1), TRPC1 (residues 726–745; 2), TRPC4 (residues 712–731; 3), and
TRPC5 (residues 719–738; 4). Interaction between TRPC1 (residues 726–745)
and the D2LIC3 is shown as a negative control (5).
Fig. 3. TRPC1 interacts with D2R in rat cortex and striatal tissue. Anti-D2R
antibodies were used to immunoprecipitate D2Rs from rat cortex and striatum
(ac — Abcam; sc — Santa Cruz; cb — Calbiochem). Blots containing
immunocomplexes (IP) were sequentially probed with anti-TRPC1 antibodies
(antibody used in top and middle panels was the monoclonal anti-TRPC1
antibody from Leonidas Tsiokas, University of Oklahoma; antibodies used in
bottom panel were from Sigma). The position of TRPC1 endogenously ex-
pressed in cortical and striatal tissue is shown (lysate lane). No signal was
observed in lysate sample adsorbed onto beads alone (Mock IP).
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within the C-terminal portion of Clone 44. In contrast, TRPC
truncation constructs D (residues 638–759) and C (residues 638–
745) tested positive with D2IC2 in the β-galactosidase assay.
These mapping studies suggest that the region in TRPC1 spanned
by residues 726–745 is required for D2R binding. The ability of
construct E (residues 726–745) to directly interact with the D2R
(Fig. 2B, D) provides very strong evidence that this region spans
a portion of the D2R binding site.
Amino acid sequence alignments were used to predict po-
tential D2R binding sites on TRPC4 and TRPC5 (Fig. 2C).
Within the C-terminal domain of TRPC1, the region encom-
passing the D2R binding domain (residues 726–745) showed
70% amino acid similarity to the comparable region in TRPC4
(residues 735–754) and 75% amino acid similarity to the com-
parable region in TRPC5 (residues 742–761). We used a
directed two-hybrid approach and tested for interaction bet-
ween the D2IC2 and truncation fragments of TRPC4 and
TRPC5 analogous to the D2R binding domain present in
TRPC1. As shown in Fig. 2D, the TRPC4 and TRPC5 trunca-
tion fragments each displayed a positive interaction with the
D2IC2 domain, and produced detectable, albeit lower, levels ofβ-galactosidase activity compared to the TRPC1/D2IC2 in-
teraction. Taken together, these results support the view that
TRPC1, TRPC4, and TRPC5 are all capable of interaction with
the D2R, and that this interaction is mediated via a conser-
ved binding domain located in the C-terminal tail of each of
the three TRPC family members.
3.3. TRPCs interact with D2Rs in rat brain and are a
component of the D2R signalplex
We examined the interaction between the D2R and TRPCs
in rat brain by coimmunoprecipitation experiments. We tested
several independent anti-TRPC1 antibodies to confirm the de-
tection of native TRPC1 protein in cell lysates as well as rat
cortex and striatum membrane preparations. All antibodies
tested reacted with a polypeptide that migrated with the expected
molecular mass of TRPC1 (between 75 kDa and 100 kDa —
data not shown). This polypeptide was identified in HEK293T
cells, HEK293-D2L cells, and rat cortex and striatum, indicating
that TRPC1 protein is endogenously expressed in each of these
cell lines and native rat tissues.
Crude membrane fractions from striatal and cortical rat tis-
sue were immunoprecipitated using anti-D2R antibodies and
immunocomplexes sequentially probed with anti-TRPC1 an-
tibodies. As shown in Fig. 3, two different TRPC1 antibodies
were capable of detecting TRPC1 immunocomplexed with
D2Rs. We were also able to immunoprecipitate the D2R with
any of three independent commercially available anti-D2R
antibodies (obtained from Abcam, Santa Cruz, or Calbiochem).
Blots were stripped and re-probed to confirm the presence of
additonal DRIPs. Immunoreactive bands corresponding in size
to TRPC1 and TRPC4 were detected within the D2R-containing
complexes (Fig. 4A, top and middle panels, respectively). In
addition, D2R-containing immunocomplexes obtained from
cortex and striatum also tested positive for the presence of the
Fig. 4. TRPCs interact with D2R and other components of the D2R signalplex.
(A)Anti-D2Rantibody (Abcam)was used to immunoprecipitateD2Rs from cortex
and striatum of rat. Blots containing immunocomplexes were sequentially probed
with anti-TRPC1 (monoclonal anti-TRPC1 antibody) and anti-TRPC4 (Chemicon)
antibodies. The positions of TRPC1 and TRPC4 endogenously expressed in
cortical and striatal tissue are shown (lysate lanes). No signal was seen in lysate
adsorbed onto beads alone (Mock IP). (B) NCS-1-GST fusion protein was used to
pull down S-tagged TRPC1 (residues 638–759) from a bacterial lysate. S-tagged
TRPC1was pulled down in the presence of NCS-1-GST, but notwithGSTor beads
alone. The position of the TRPC truncation fragment is shown in the lysate lane.
Fig. 5. Expression profile of TRPC1 and D2Rs in neurons of the PFC.
(A) Immunolabeling of TRPC1 subunits in the perikarya and dendrites of
cortical neurons. TRPC1 immunolabeling was found in association with the
(granular and agranular) endoplasmic reticulum and along the trans-Golgi axis
(large inset). A limited plasmalemmal expression was also found at or near sites
of juxtaposition of smooth endomembranes (small inset). (B) D2R expression
was predominantly localized to (extrasynaptic) membrane-bound compartments
of high-order dendritic branches (den), and virtually absent in nearby axo-
spinous (ax-sp) synapses. Scale bars: (A) 1 μm; (A insets) 200 nm; (B) 400 nm.
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our two-hybrid and pulldown results indicate that TRPC5
and D2Rs also interact, we were unable to detect TRPC5 in
D2R-containing immunocomplexes (data not shown). Failure to
detect TRPC5 channels most likely reflects the poor quality of
commercially available anti-TRPC5 antibodies [26].
Previous experiments we have carried out demonstrated a
direct interaction between the DRIP, NCS-1, and TRPC5 [34].
We used pulldown techniques to examine whether TRPC1 and
NCS-1 might also directly interact. A lysate prepared from
bacteria expressing an S-tagged TRPC1 C-terminal fragment
(residues 638–759) was tested for the ability to associate with
an NCS-1-GST fusion protein. As shown in Fig. 4B, the lysate
produced an immunoreactive band of ~18 kDa, the expected size
of the TRPC1 fragment, when probed with an anti-S-protein
antibody. The same band was detected after the bacterial lysate
was incubated with the NCS-1-GST fusion protein, but not when
the lysate was absorbed onto either GST or beads alone. These
results support the idea that TRPC1 interacts directly with the
D2R as well as additional components of the D2R signalplex.
3.4. TRPC1 and D2Rs colocalize in postsynaptic compartments
of cortical neurons
Immunohistochemical analysis of monkey prefrontal cortex
(PFC) was used to gain insight into the subcellular distribution
of TRPC1 and D2Rs. As shown in Fig. 5A, TRPC1 immu-
noreactivity was detected in both the cell body and the dendri-
tic shafts of PFC pyramidal neurons, where immunoparticles
were found in association with the trans-Golgi network and
with the endoplasmic reticulum (Fig. 5A). A fraction of TRPC1
immunoreactivity was also localized at the plasma membrane,
and often occurred at sites opposite smooth reticular endomem-branes (Fig. 5A). Similarly, D2R immunolabeling was also
found in the cell body (where it often decorated cisternae of the
rough endoplasmic reticulum) and extrasynaptically in higher
order dendrites (Fig. 5B). Consistent with earlier studies [27],
D2Rs were found associated with the plasma membrane as
well as intracellular compartments (Fig. 5B). In general, D2R
expression within the PFC was considerably weaker than
TRPC1 when comparing antibody reactivity.
Double immunoelectron microscopic analysis of monkey PFC
was used to examine the subcellular colocalization of TRPC1 and
D2Rs. Peroxidase labeling of TRPC1 produced a diffuse preci-
pitate that contrasted with the D2R immunogold particles (Fig. 6,
A–D). TRPC1 labeling was found to colocalize with D2R ex-
pressionwithin dendritic branches expressing both cytoplasmic and
membrane-bound D2Rs (Fig. 6B, C). In addition, TRPC1 labeling
colocalized with D2R immunolabeling at the plasma membrane
(Fig. 6A). Reversal of the immunocytochemical sequence (i.e.,
peroxidase-labeled D2R, gold-labeled TRPC1) corroborated these
findings and demonstrated that the two immunoprobes clearly
overlap on endoplasmic membranes (Fig. 6D).
Fig. 6. Colocalization of D2R and TRPC1 in the cortex. (A–C) TRPC1 labeled with immunoperoxidase is shown in dendritic branches expressing both cytoplasmic
and plasmalemmal D2R immunoparticles (arrowheads). Note that the diffuse TRPC1 labeling in A (indicated by bracket within frame) is restricted to a portion of the
dendrite and overlaps with the expression of D2Rs at the plasma membrane (frame). Other profiles reactive for D2R alone are seen in A and C. To test for reagent and
method selectivity, we reversed the immunocytochemical sequence. In D, D2R labeling with immunoperoxidase overlaps with TRPC1 immunoparticles (double
arrowheads) within membranes of intracellular compartments of a primary dendrite (lower inset). In E and C, dual nanogold labeling for D2Rs (large particles;
arrowheads) and TRPC1 (small particles; double arrowheads) shows that immunoprobes are often separated by fewer than 50 nm. (F) Spatial colocalization of D2R
and TRPC1 immunoparticles strongly suggests that the two proteins are physically associated at the plasma membrane of dendrites. Asterisks mark a subsurface
cistern; ax, axon; den, dendrite; sp, spine. Scale bars: 200 nm.
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to label TRPC1 and D2Rs on single sections of monkey PFC
(Fig. 6E, F). TRPC1 and D2Rs exhibited comparable distribu-
tion patterns within individual subcellular compartments and
organelles (Fig. 6E, F). Spatial co-expression of TRPC1 and
D2R immunosignals (i.e. those cases where the two immuno-
probes could be found separated by less than 20 nm as determined
by the maximum linear dimension of both immunocomplexes)
was often observed at extrasynaptic sites of the plasma
membrane (Fig. 6F). The close spatial proximity of TRPC1 andD2R immunoreactivity demonstrates that the two proteins co-
localize within neurons, and provides compelling evidence for
a physical interaction between these binding partners in the primate
cortex.
3.5. TRPC1/D2R interaction mediates cell surface expression
of TRPC1 proteins
To help determine the functional significance of the TRPC1/
D2R interaction, we used a cell surface biotinylation assay to
Fig. 7. TRPC1/D2R interaction mediates cell surface expression of TRPC1. A cell surface biotinylation assay was used to examine the effect of the D2R on plasma
membrane expression of TRPC1. HEK293, HEK293-D2L, and HEK293-MOR cell surface proteins were biotinylated by incubation with NHS-SS-biotin. Biotinylated
membrane proteins were immunoprecipitated using an anti-TRPC1 antibody (Alomone) and TRPC1 proteins quantitated by densotimetric analysis. (A) Anti-TRPC1
antibody was used to immunoprecipitate TRPC1 proteins from HEK293 and HEK293-D2L cells. Immunoblots were probed for the presence of biotin to identify cell
surfaced-expressed TRPC1. (B) Total expression of TRPC1 in crude membrane fractions prepared from HEK293 and HEK293-D2L cells. (C) Biotinylated TRPC1
proteins in Awere quantitated by laser densitometry. (D) Anti-TRPC1 antibody was used to immunoprecipitate TRPC1 from HEK293-MOR and HEK293-D2L cells.
(E) Total expression of TRPC1 in HEK293-D2L and HEK293-MOR cells. (F) Biotinylated TRPC1 proteins in Dwere quantitated by laser densitometry. HEK293-D2L
cells stably expressing D2Rs show an approximately 50% increase in the level of cell surface TRPC1 proteins (Student's two-tailed t test, n=6, ⁎pb0.05) compared to
either HEK293 cells or HEK293-MOR cells (n=4. ⁎pb0.05). (G) Anti-TRPC1 antibody was used to immunoprecipitate TRPC1 proteins from HEK293-D2L and
HEK293-MOR cells. Blots containing TRPC1 immunocomplexes were probed with anti-FLAG antibodies to identify D2L-FLAG andMOR-FLAG proteins. D2R and
TRPC1 coimmunoprecipitated from HEK293-D2L cells, whereas TRPC failed to coimmunoprecipitate with the MOR expressed in HEK293-MOR cells.
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the plasma membrane. We took advantage of the fact that wild-
type HEK293 and HEK293-D2L cells endogenously express
similar levels of TRPC1 (Fig. 7B), whereas only HEK293-D2L
cells express D2Rs. HEK293 and HEK293-D2L cell surface
proteins were biotinylated by incubation with NHS-SS-biotin.
Biotinylated membrane proteins were immunoprecipitated us-
ing an anti-TRPC1 polyclonal antibody (Alomone) and TRPC1
proteins quantified by densitometric analysis. As shown in Fig. 7
(A and C), HEK293-D2L cells displayed a two-fold increase in
the numbers of cell surface TRPC1 channels compared with
wild-type HEK293 cells. Similar results were obtained with an
independent (Sigma) anti-TRPC1 antibody [26].
We also examined the cell surface expression of TRPC1 in
HEK293 cells stably transfected with the µ-opioid receptor
(HEK293-MOR cells). As shown in Fig. 7E, HEK293-D2L and
HEK293-MOR cells endogenously express similar levels of
TRPC1. However, HEK293-D2L cells exhibit an approximately
two-fold increase in the numbers of cell surface TRPC1 chan-
nels compared with HEK293-MOR cells (Fig. 7D and F). In
control experiments, we found that the D2R and TRPC1 coim-munoprecipitated fromHEK293-D2L cells, whereas TRPC failed
to coimmunoprecipitate with the MOR expressed in HEK293-
MOR cells (Fig 7G). These results are consistent with the idea that
the TRPC1/D2R interaction is required for the proper trafficking
and/or expression of TRPC1 channels at the plasma membrane.
4. Discussion
TRPC channels are believed to play an important role in
regulating calcium entry into cells [20,22]. The presence of a
signalplex containing D2Rs and TRPC1 suggests that D2Rs
can impact cellular calcium signaling by coupling to TRPC
channels. It is interesting to note that this is the first instance in
which a direct interaction has been observed between a TRPC
channel and a GPCR. Previous studies have demonstrated that
TRPC channels are activated mainly by Gq-protein coupled
receptor stimulation. Our results thus point to a novel mecha-
nism of GPCR/TRPC channel regulation that may involve direct
protein–protein interaction.
In this study,we present a variety of criteria establishingTRPC1,
TRPC4, and possibly TRPC5, as bona-fide DRIPs. Among the
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TRPC5 comprise a sequence-related subgroup in which TRPC1
can form heteromeric channels with either TRPC4 or TRPC5
(reviewed in [19,33]). In GST-pulldown experiments, we detected
interaction ofD2Rwith the C-terminal segment of TRPC1, TRPC4
and TRPC5, a region known to interact with several TRPC binding
partners including the IP3R and CaM [32,33,35–37]. Interaction of
the D2R with TRPC1 and TRPC4 was validated by coimmuno-
precipitation of the binding partners directly from rat brain. How-
ever, we could not confirm interaction of the D2R with TRPC5
by coimmunoprecipitation, suggesting that D2Rs maintain speci-
ficity in their interaction with TRPC channels.
Our biotinylation studies indicate an increase in cell surface
expression of TRPC1 in cells expressing the D2R, suggesting
that interaction between TRPC and the D2R regulates the traf-
ficking/stability of TRPC1 at the plasma membrane. At pre-
sent, it is not clear if the net increase in TRPC1 at the plasma
membrane represents a net increase in TRPC1 trafficking to
the cell surface or an increase in the stability of TRPC1 chan-
nels already at the cell surface. In this context, it is interesting
to consider that treatment of cells with D2R agonists such as
dopamine or quinpirole did not appear to have an effect on
the cell surface expression of TRPC1 when compared to non-
treated cells [26]. These results suggest that physical assem-
bly of the TRPC1/D2R complex is sufficient for promoting
TRPC1 trafficking to the plasma membrane, and may be a
key determinant in the receptor-mediated activation of these
channels.
In the future it will be important to determine whether the
D2R/TRPC interaction can modulate the electrophysiological
properties of cell surface-associated TRPC channels. Several
recent studies point to a functional relationship between D2Rs
and TRPC channels in the brain. It has been shown, for example,
that TRP-like currents can be evoked via D2-like dopaminergic
stimulation of rat dorsal raphe serotonin neurons [38]. Electro-
physiological recording from rat brain slices of the dorsal
raphe nucleus, a region known to express D2R [39,40] as well
as TRPC1 proteins [39–41], demonstrated the presence of a
reversible slow membrane depolarization in response to sti-
mulation with dopamine or quinpirole. This current was found
to be abolished in the presence of the D2-like antagonist sul-
pride, and attenuated by the TRP channel inhibitors 2-APB and
SKF-9636, suggesting that TRPC channels are responsible for
the dopamine stimulated slow membrane depolarization current
in dorsal raphe nucleus serotonin neurons [38].
Calcium entry through plasma membrane TRPC channels is
believed to play an important role in a plethora of cellular
events in both excitable and non-excitable tissue [19,20]. More-
over, it has been suggested that alterations in the calcium
signaling properties of DRs contribute to several neuropathol-
ogies including schizophrenia and bipolar disorder [42]. Pre-
vious studies have shown that expression of NCS-1, a D2R
interacting protein, is altered in patients with schizophrenia
[10,43] as well as in mice treated with antipsychotic drugs [44].
It is of particular interest that TRPC1 and TRPC5 also interact
with NCS-1. In view of the critical roles assumed by TRPCs
in regulating key neural functions, including neurite extensionand growth cone guidance [45–47], it will be important to
determine if alterations in expression or function of TRPC
occur in diseases associated with dysregulation of dopamine
neurotransmission. Alterations in TRPC protein expression or
function could have a profound effect on the proper trafficking
and/or signaling properties of the D2R signalplex. In this con-
text, it is interesting to consider that alterations in TRPC7 ex-
pression have recently been reported in patients with bipolar
affective disorder [48].
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